<DOC>
	<DOCNO>NCT01605448</DOCNO>
	<brief_summary>The investigator investigate benefit mind/body intervention , Mindfulness Based Stress Reduction , adult Mild Cognitive Impairment .</brief_summary>
	<brief_title>Mindfulness Based Stress Reduction Adults With Mild Cognitive Impairment</brief_title>
	<detailed_description>We propose prospective , randomize control pilot trial assess feasibility safety study investigate mindfulness base stress reduction ( MBSR ) intervention adult Mild Cognitive Impairment ( MCI ) . We assess safety feasibility intervention , well use neuroimaging ( fMRI ) ass improved connection default mode network . We also assess impact intervention cognitive function measure well-being .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Clinical diagnosis MCI* make neurologist ( history , physical exam neuropsychological testing ) 1 . Memory complaint , corroborate informant 2 . Abnormal memory function document memory test &lt; 1.5 standard deviation normative control ( assess Wechsler Memory scale IV [ 114 ] , Logical Memory subtest , equivalent test ) 3 . Normal general cognitive function 4 . MiniMental Status Exam ( MMSE ) score &gt; 24 30 5 . No/minimal impairment activity daily live 6 . Not sufficiently impair , cognitively functionally , meet National Institute Neurological Communicative Disease Stroke/Alzheimer 's Disease Related Disorders Association criterion AD 6090 yo Clinical Dementia Rating ( CDR total score 0.5 , least 0.5 memory subscale No history significant cerebrovascular disease base Modified Hachinski score ≤ 4 Hamilton Depression Rating Scale score ≤12 ( rule depression contribute cause cognitive decline ) Able willing attend weekly session willing participate daily mindfulness assignment , 45 min/day Agreeable participate randomize either group Fluent English ( since treatment group run English ) Adequate visual auditory acuity allow neuropsychological test Good general health additional disease expect interfere study MRI/CT scan within 24 month without indication infection , infarction , focal lesion . Family member/close friend ( `` informant '' ) able corroborate participant 's history memory loss Participants may take stable dos ( stable least 4 week prior screen ) certain medication include : Antidepressants ( except significant anticholinergic side effect tricyclic antidepressant ) . Patients currently depress history major depression within past 2 year Cholinesterase inhibitor memantine Actively practice meditation and/or yoga take meditation/yoga class last 6 month Any major systemic illness unstable medical condition could lead difficulty comply protocol , include diagnosis major depression On psychoactive medication ( antidepressant anticholinergic effect , ie . tricyclic antidepressant , neuroleptic , chronic anxiolytic , sedative hypnotic , anticholinergic ) ; participant may take stable dos ( stable least 6 month ) low dos psychoactive medicine ( i.e . ≤ 1mg klonipin/day ≤25mg Benadryl/day ) Psychotic feature , agitation , behavioral problem within last 3 month could lead difficulty comply protocol History alcohol substance abuse dependence within past 2 year Any history brain lesion major head trauma Participant unable/unwilling follow protocol return followup Investigational agent prohibit entry duration trial Participation clinical study involve neuropsychological measure collect one time per year MRI exclusion : presence pacemaker , aneurysm clip , artificial heart valve , ear implant , metal fragment foreign object eye , skin body .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Meditation</keyword>
	<keyword>Default Mode Network</keyword>
</DOC>